Stratos Genomics Inc., a Seattle, WA-based developer of a single-molecule detection process – called ‘Sequencing by Expansion’ (SBX™) – that allows whole genome sequencing, has closed a $4m Series A financing deal.
The round was led by Fisk Ventures, with participation from Stratos Group LLC, from which the company spun put in 2007.
The funds will be used to continue development of Stratos Genomics’ ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics.
Commenting on the financing, Stratos Genomics CEO, Allan Stephan, said: “We are pleased to have the support of Fisk Ventures as we continue developing technology that will play an important role in the future of medicine and genomic sciences”.
FinSMEs
08/09/2010